Caricamento...
Improvement in pain severity category in clinical trials of pregabalin
BACKGROUND: Pregabalin is approved by the US Food and Drug Administration for the treatment of fibromyalgia (FM), diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN), and neuropathic pain due to spinal cord injury (SCI). Approval was based on clinical trial data demonstrating statisti...
Salvato in:
| Pubblicato in: | J Pain Res |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5063480/ https://ncbi.nlm.nih.gov/pubmed/27785092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S102696 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|